Events

Congenital heart disease is the leading cause of death for infants born with birth defects and represents 1% of births in the USA, and, according to the NIH, that is 8 out of every 1,000 newborns. CHD is the most common type of birth defect. CHD includes single ventricle disease (Hypolastic Left Heart Syndrome – HLHS), Tetralogy of Fallot, transposition of the great arteries, and aortic coarctation name of few such CHD malformations. Successful treatment of CHD present opportunities to improve quality of life for individuals afflicted with this disease with consequent benefit to society. Over 1 million adults in the USA are living with congenital heart defects (http://www.nhlbi.nih.gov/health/health-topics/topics/chd).

The field of engineering applications in congenital heart disease has undergone an explosive growth in both application and development nationally and worldwide over the past decades. The cutting edge problems that are the subject of this conference are at the interface of engineering and medicine. The 5th International Conference on Engineering Frontiers in Pediatric and Congenital Heart Disease aims to bring together professionals in both the engineering and medical disciplines to foster collaboration between these two communities in the study of treatment of congenital heart disease.

History of the Conference Series: This is the fifth in a series of meetings organized and held by the University of California at San Diego in the USA (2010), Great Ormond Street Hospital in London UK (2011), Stanford Medical School in Palo Alto USA (2012), and INRIA-Rocquencourt in Versailles, France (2014). The current meeting will be held at the University of Central Florida College of Medicine at Lake Nona in Orlando Florida June 9 & 10, 2016. This series brings together medical professionals, surgeons, and clinicians with engineers from academia and industry with the aims of facilitating and promoting translational engineering modeling research in the area of pediatric congenital heart disease.